Advertisement

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens

Anja Mottok, Vindi Jurinovic, Pedro Farinha, Andreas Rosenwald, Ellen Leich, German Ott, Heike Horn, Wolfram Klapper, Michael Boesl, Wolfgang Hiddemann, Christian Steidl, Joseph M. Connors, Laurie H. Sehn, Randy D. Gascoyne, Eva Hoster, Oliver Weigert and Robert Kridel

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 4, 2017
  • Accepted October 27, 2017
  • Published online November 9, 2017.


Contributors 
  • Anja Mottok, 1 Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;
  • Vindi Jurinovic, 2 Medical Department III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany;
  • Pedro Farinha, 3 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;
  • Andreas Rosenwald, 4 Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Centre Mainfranken, Wuerzburg, Germany;
  • Ellen Leich, 4 Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Centre Mainfranken, Wuerzburg, Germany;
  • German Ott, 5 Department of Clinical Pathology, Robert-Bosch-Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
  • Heike Horn, 6 University of Tuebingen, Tuebingen, Germany;
  • Wolfram Klapper, 7 Dept. of Pathology, Hematopathology Section and Lymph Node Registry, University Kiel, Kiel, Germany;
  • Michael Boesl, 2 Medical Department III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany;
  • Wolfgang Hiddemann, 2 Medical Department III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany;
  • Christian Steidl, 1 Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;
  • Joseph M. Connors, 1 Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;
  • Laurie H. Sehn, 1 Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;
  • Randy D. Gascoyne, 1 Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;
  • Eva Hoster, 8 Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig Maximilians University Munich, Munich, Germany;
  • Oliver Weigert, 2 Medical Department III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany;
  • Robert Kridel, 9 Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output